Family planning messages on sanitary pad packaging
Official title: The Effect of Written and Visual Messages on Sanitary Nap Packagig on Women's Knowledge and Attitudes Towards Family Planning: a Randomized Controlled Ctudy
Run by Ondokuz Mayıs University · NCT07012369 · Data updated 2026-11-12
This project will test whether written and picture messages printed on sanitary pad packaging help postpartum women with babies 9–18 months old learn more about and change their attitudes toward family planning.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 49 Years |
| Sex | Women only |
| Enrollment | 50 (estimated) |
| Sponsor | Ondokuz Mayıs University Academic / other |
| Locations | 1 site (Samsun) |
| Status | Recruiting |
| Started | January 5, 2025 |
| Main results expected | June 15, 2025 |
| Study ends | July 1, 2025 |
| Registry record updated | June 10, 2025 |
| Trial ID | NCT07012369 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are married, sexually active postpartum women with babies aged 9–18 months who have at least a primary school education, use a smartphone, are not using modern contraceptive methods, and can attend the Family Health Centers in Atakum.
✕Probably not a fit
Women already using modern family planning methods, those who received postpartum family planning training, or those with medical conditions or surgeries affecting fertility or the menstrual cycle are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled experiment conducted at Family Health Centers in the Atakum district of Samsun between January 2024 and January 2025. Eligible postpartum women (baby aged 9–18 months) who are married, sexually active, have a regular menstrual cycle, a primary-school education, and do not use modern contraceptive methods will be randomized to receive sanitary pads with written and visual family planning messages or to a control group that receives no materials. The intervention aims to use packaging as a repeated, low-cost communication channel to influence knowledge and attitudes about family planning. Outcomes will compare changes in knowledge and attitude measures between the intervention and control groups using the planned sample size of roughly 39 participants per arm (with additional participants to increase power).
Why it matters
Potential benefit: If successful, printing family planning information on sanitary pad packaging could increase women's knowledge and positive attitudes about modern contraception and be a low-cost way to promote uptake.
How similar studies have gone: Health messaging via product packaging (for example cigarette warnings) has influenced behavior in other contexts, but using sanitary pad packaging specifically for family planning is novel with limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women who are at least primary school graduates, * Those who have a baby aged 9-18 months, * Those who do not use AP methods or traditional AP methods (withdrawal, Calendar method), * Those who are married and have a sexual partner, * Those who have an active sexual life, * Those who have a regular menstrual cycle, * Those who do not have any obstacles that prevent communication, * Those who are willing to give their phone number, * Those who use a smartphone, * Women who are at least primary school graduates will be included. Exclusion Criteria: * Those who received family planning training in the postpartum period, * Those who use modern FP methods, * Those who underwent hysterectomy surgery due to complications such as bleeding in the postpartum period, * Those who have a history of infertility and became pregnant with assisted reproductive techniques, * Those who have any health problems (such as thyroid, cancer) that negatively affect the menstrual cycle, * Those who have any chronic diseases (such as cancer, diabetes, hypertension, hypercholesterolemia, heart disease, etc.) or use of medications (such as diuretics, antihypertensives, antihistamines, anticholinergics, etc.) that negatively affect sexual health, * Those who are pregnant or planning to get pregnant again, * Women who do not agree to participate in the study or who give up participating in the study or provide incorrect or incomplete information will not be included in the study.
Where it's running
-
Ondokuz Mayıs University
Samsun, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Yasemin Sökmen, Asist prof
- Email: ysmn0006@outlook.com
- Phone: 905342595088
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Helping Men Care for Loved Ones: IN-HOME Outreach for Male Caregivers
This study tests whether outreach from IN-HOME-trained community health workers helps male caregivers improve their knowledge, skills, and confidence, and see if it boosts their health and daily functioning.
-
Improving HPV vaccination and adolescent health in Laos
This study is testing if adding HPV vaccinations to health services for young teens in Laos can help more girls get vaccinated and improve their overall health care.
-
Senior Center Medication Safety and Empowerment Curriculum
A program for adults 55+ and their care partners to learn how to safely manage medications and talk with doctors about safer options.
-
Effectiveness of the Natural Cycles birth control app
This study will test how well the Natural Cycles app prevents pregnancy over one year in sexually active women aged 18 to 35 with no known infertility.
-
Female Reproductive Health in the Canadian Armed Forces: Understanding Issues from Contraception to Pelvic Floor Dysfunction
This observational study looks at reproductive health among women in the Canadian Armed Forces to see how contraception, pregnancy outcomes, infertility, pelvic floor issues, and related factors affect service members and veterans.
-
Long-acting HIV PrEP and contraception PK study in AGYW
This study tests how long-acting cabotegravir for PrEP interacts with hormonal contraception in young women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.